Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

One year recurrence of aberrant crypt foci.

Pinsky PF, Fleshman J, Mutch M, Rall C, Charabaty A, Seligson D, Dry S, Umar A, Schoen RE.

Cancer Prev Res (Phila). 2010 Jul;3(7):839-43. doi: 10.1158/1940-6207.CAPR-09-0257. Epub 2010 Jun 22.

2.

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.

Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG; Adenoma Prevention with Celecoxib (APC) Study Investigators.

Cancer Prev Res (Phila). 2010 May;3(5):588-96. doi: 10.1158/1940-6207.CAPR-09-0271. Epub 2010 Apr 19.

3.

Long-term use of statins and risk of colorectal cancer: a population-based study.

Singh H, Mahmud SM, Turner D, Xue L, Demers AA, Bernstein CN.

Am J Gastroenterol. 2009 Dec;104(12):3015-23. doi: 10.1038/ajg.2009.574. Epub 2009 Oct 6.

PMID:
19809413
4.

Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.

Gupta AK, Pinsky P, Rall C, Mutch M, Dry S, Seligson D, Schoen RE.

Gastrointest Endosc. 2009 Aug;70(2):322-30. doi: 10.1016/j.gie.2008.12.060. Epub 2009 Jun 21.

5.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

6.

A multicenter study of prevalence and risk factors for aberrant crypt foci.

Mutch MG, Schoen RE, Fleshman JW, Rall CJ, Dry S, Seligson D, Charabaty A, Chia D, Umar A, Viner J, Hawk E, Pinsky PF.

Clin Gastroenterol Hepatol. 2009 May;7(5):568-74.

PMID:
19418605
7.

Aberrant crypt foci in the adenoma prevention with celecoxib trial.

Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM.

Cancer Prev Res (Phila). 2008 Jun;1(1):21-31. doi: 10.1158/1940-6207.CAPR-07-0011. Epub 2008 Apr 14.

8.

Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention.

Lance P, Hamilton SR.

Cancer Prev Res (Phila). 2008 Jun;1(1):4-8. doi: 10.1158/1940-6207.CAPR-08-0043. Epub 2008 Apr 14. No abstract available.

9.

Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?

Gupta AK, Schoen RE.

Curr Opin Gastroenterol. 2009 Jan;25(1):59-65. doi: 10.1097/MOG.0b013e32831db286. Review.

PMID:
19114775
10.

Chemoprevention of colorectal cancer: feasibility in everyday practice?

Herszényi L, Farinati F, Miheller P, Tulassay Z.

Eur J Cancer Prev. 2008 Nov;17(6):502-14. doi: 10.1097/CEJ.0b013e3282f0c080. Review.

PMID:
18941372
11.

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW.

Cancer Prev Res (Phila). 2008 Jun;1(1):32-8. doi: 10.1158/1940-6207.CAPR-08-0042.

12.

Chronic statin therapy and the risk of colorectal cancer.

Yang YX, Hennessy S, Propert K, Hwang WT, Sarkar M, Lewis JD.

Pharmacoepidemiol Drug Saf. 2008 Sep;17(9):869-76. doi: 10.1002/pds.1599.

PMID:
18412290
13.

Statins in tumor suppression.

Sassano A, Platanias LC.

Cancer Lett. 2008 Feb 18;260(1-2):11-9. doi: 10.1016/j.canlet.2007.11.036. Epub 2008 Jan 3. Review.

PMID:
18180097
14.

The natural history of aberrant crypt foci.

Schoen RE, Mutch M, Rall C, Dry SM, Seligson D, Umar A, Pinsky P.

Gastrointest Endosc. 2008 Jun;67(7):1097-102. doi: 10.1016/j.gie.2007.08.048. Epub 2008 Feb 21.

PMID:
18178205
15.

Chemoprevention of colorectal cancer.

Das D, Arber N, Jankowski JA.

Digestion. 2007;76(1):51-67. Epub 2007 Oct 19. Review.

PMID:
17947819
16.

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.

Bonovas S, Filioussi K, Flordellis CS, Sitaras NM.

J Clin Oncol. 2007 Aug 10;25(23):3462-8.

PMID:
17687150
17.

Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.

Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF.

Gastroenterology. 2007 Aug;133(2):393-402. Epub 2007 May 21.

PMID:
17681160
18.

Chromoendoscopy.

ASGE Technology Committee, Wong Kee Song LM, Adler DG, Chand B, Conway JD, Croffie JM, Disario JA, Mishkin DS, Shah RJ, Somogyi L, Tierney WM, Petersen BT.

Gastrointest Endosc. 2007 Oct;66(4):639-49. Epub 2007 Jul 23. Review. No abstract available.

PMID:
17643437
19.

Aberrant crypt foci: what we know and what we need to know.

Gupta AK, Pretlow TP, Schoen RE.

Clin Gastroenterol Hepatol. 2007 May;5(5):526-33. Epub 2007 Apr 12. Review.

PMID:
17433788
20.

Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients.

Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Van Loo J, Watzl B, Collins JK.

Am J Clin Nutr. 2007 Feb;85(2):488-96.

PMID:
17284748

Supplemental Content

Support Center